All trials - page: 33

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT06831240New Rear Anti-tip Device for Manual Wheelchairs: Subjective Input (RAD-SI)Nova Scotia Health Authority
  • Age ≥ 18 yrs
  • Level C1-S5
  • AIS
  • All
  • be wheelchair users
Recruiting soon150General health1 year15 April 202518 February 20251
NCT06839300The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) StudyAO Foundation, AO Spine
  • Age ≥ 19 yrs
  • Level C1-L1
  • AIS A, B, C, D
  • ≤ 24 null
  • NOT have a penetrating SCI (eg, gunshot, stab)
Recruiting soon260General health
  • American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
  • Magnetic Resonance Imaging (MRI) - conventional/anatomical and quantitative
  • Serum Biomarker
1 year01 November 202521 February 20250
NCT06847295Epidural Electrical Stimulation to Restore Standing and Walking in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Study on Motor Recovery, Spasticity Reduction, and Quality of Life Improvement Through Neuromodulation and Intensive RehabilitationUniversity of Sao Paulo General Hospital
  • Age 18 - 50 yrs
  • Level C7-T10
  • AIS A, B
  • ≥ 6 months
  • NOT currently use electronic devices such as baclofen pumps or cardiac pacemakers
Recruiting10NATechnologyStanding/walking/mobility
  • Ashworth and Modified Ashworth Scale (MAS)
  • Beck Depression Inventory (BDI)
  • Berg Balance Scale (BBS)
  • Brief Pain Inventory (BPI)
  • Fugl-Meyer Assessment (FMA)
  • Neurogenic Bladder Symptom Score
  • Neurogenic Bowel Dysfunction Score (NBD or NBDS)
  • World Health Organization Quality of Life- BREF (WHOQOL-BREF)
12 months28 January 202226 February 20251
NCT06274021Neuromodulation to Reduce Muscle Stiffness Following Spinal Cord InjuryUniversity of Mississippi Medical Center
  • Age ≥ 18 yrs
  • Level C1-T11
  • AIS
  • ≥ 6 months
  • NOT have an implanted active devices
  • NOT have passive implants (plates, screws) below the level of injury
  • HAVE presence of spasticity in the lower limbs
Recruiting16EARLY_PHASE1TechnologySpasticity
  • Ashworth and Modified Ashworth Scale (MAS)
  • Spinal Cord Assessment Tool for Spastic Reflexes (SCATS)
5 weeks01 March 202423 February 20242
NCT05965700NVG-291 in Spinal Cord Injury SubjectsNervGen Pharma
  • Age 18 - 75 yrs
  • Level C1-C8
  • AIS B, C, D
  • 20 days - 90 days
  • NOT have a spinal cord injury due to gunshot wound or penetrating injury
  • NOT have an implanted device in the brain or spinal cord
  • NOT have an implanted pacemaker
  • be able to volitionally initiate at least one step (without body weight support
Recruiting40PHASE1, PHASE2DrugStanding/walking/mobility
  • 10 Meter Walking Test (10 MWT)
  • Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
  • Hand-Held Myometery / Dynamometry
  • Motor evoked potential
16 weeks08 August 202328 July 20231
NCT04288245Targeted Plasticity Therapy for Upper Limb Rehabilitation in Spinal Cord InjuriesBaylor Research Institute
  • Age 18 - 64 yrs
  • Level C1-C8
  • AIS B, C, D
  • ≥ 12 months
20NATechnologyArm/hand function
  • Adverse Events (AEs)
  • Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
2 years15 February 202128 February 20201